CTRI/2024/07/070555Not yet recruitingUnknown
An Open Label, prospective, Randomized, Placebo Controlled, Three-Treatment, Parallel, Comparative Trial to determine the safety, efficacy and ease of use of Transdermal Application of Multi Nutrient lotion manufactured by Murlikrishna Pharma Pvt. Ltd., India with standard Supportive Care Treatment infemale patients with mild Anemia - NI
Murali Krishna Pharma Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Subjects meeting following criteria will be included in the study:
- •1. Female patients with age 18-50 years (both inclusive), residing in the study area.
- •2. Iron deficiency anemia with low hemoglobin ranging from 9-10.9 g/dL at the onset of the study (at first visit).
- •3. Patient is willing to give informed consent, able to provide availability for the entire study period and follow study protocol
Exclusion Criteria
- •1.Women or girls with significant co-morbidities including hemoglobinopathies.
- •2.Patients who have received blood or blood products transfusion during the current illness
- •3.Patients with generalized skin disorder hampering the regular application transdermal of investigational drug
- •4.Pregnant and lactating women
Investigators
Similar Trials
Completed
Not Applicable
A study to evaluate the Safety and Effectiveness of Alkaline Drink on Body Hydration, Acidity Regulation and Detoxification.CTRI/2022/10/046499A V Organics34
Completed
Phase 2
A randomised, open label, placebo controlled exploratory study in healthy volunteers, to characterise the acid neutralisation activity of sodium alginate oral suspension in the fasted state, using a custom-designed intragastric and oesophageal pH catheterGORDgastric acid refluxheartburnNL-OMON41075Reckitt Benckiser Healthcare (UK) Ltd24
Withdrawn
Not Applicable
A randomized, open-label, cross-over, placebo-device study investigating critical and over all errors, training/teaching time, and preference attributes of the ELLIPTA dry powder Inhaler (DPI) as compared to HandiHaler DPI used in combination with either DISKUS DPI or Turbuhaler DPI, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 206215)NL-OMON45492GlaxoSmithKline125
Not yet recruiting
Not Applicable
To evaluate the safety of treatment of SNS-01/16 in healthy adult human female volunteers in fasting conditions.CTRI/2017/02/007959Cholayil Pvt Ltd20
Not yet recruiting
Phase 3
Effect of Homoeopathic treatment for manic patientCTRI/2024/06/069264Central Council for Research in Homoeopathy